Regulatory & Reimbursement
Pathways' Pick of the Week: AdvaMed’s AI Takes
AdvaMed sends AI policy priorities to Capitol Hill. Excerpted from Pathways’ Picks May 15: AI Activity, EU Priorities, China Classifications, and More.
Welcome to MyStrategist.
MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter BrowseStart a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Pathways’ Pick of the Week
Pathways' Pick of the Week: Medicare Advantage Transparency
MDMA calls for more disclosure from Medicare Advantage plans. Excerpted from Pathways’ Picks June 5: EU Elections, Medicare Picks, Lab Lawsuit, and More.
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with Market Pathways.
Subscribe Free Premier Issue Learn More
Pathways’ Pick of the Week
Pathways' Pick of the Week: Medicare Advantage Transparency
MDMA calls for more disclosure from Medicare Advantage plans. Excerpted from Pathways’ Picks June 5: EU Elections, Medicare Picks, Lab Lawsuit, and More.
Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.
Subscribe Now Learn More
Pathways’ Pick of the Week
Pathways' Pick of the Week: UK Remaps Medtech Pathways
NHS and NICE propose an integrated, rules-based medical technology pathway. Excerpted from Pathways’ Picks May 29: Rethinking Medtech Pathways in the EU, UK, and New Zealand.